Clinical Trial Update: A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on the effects of ziprasidone for schizophrenia or schizoaffective disorder in patients switched from other antipsychotic drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizoaffective Disorder, Schizophrenia | Phase 4 | Status: COMPLETED